Global Cannabidiol Market

Cannabidiol Market Size, Share, Growth Analysis, By Source(Hemp, Marijuana), By Sales Type(Online Channel, Offline Channel), By End Use(Medical, Personal Use), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35I2339 | Region: Global | Published Date: September, 2024
Pages: 173 | Tables: 90 | Figures: 66

Cannabidiol Market News

  • Akumentis Healthcare, a pharmaceutical organization based in India, announced the launch of a new synthetic cannabidiol called Calepsi in January 2024. The new product was aimed at treating epilepsy in India.
  • A new cannabidiol lozenge was launched in September 2024 by the Canadian medical cannabis company called Aurora Cannabis Inc. and Vectura Fertin Pharma Inc. The product was made available through Vectura Fertin Pharma’s e-commerce platform.
  • Gynica, a new company based in Israel announced its plans to launch the trial of its new cannabinoid-based therapies by the end of 2024. The new therapies were intended to be used for the treatment of endometriosis.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Cannabidiol Market size was valued at USD 6.48 billion in 2022 and is poised to grow from USD 7.7 billion in 2023 to USD 24.9 billion by 2031, growing at a CAGR of 15.8% during the forecast period (2024-2031).

Cannabidiol providers should focus on targeting countries and regions where legalization of cannabis is increasing to maximize their business scope. Growing incorporation of cannabidiol in multiple consumer products will also create new opportunities for cannabidiol companies going forward. Raising awareness regarding benefits of cannabidiol use will also be highly crucial for cannabidiol companies to unlock the full market growth potential. 'ENDOCA ', 'Cannoid, LLC ', 'Folium Europe B.V. ', 'Canopy Growth Corporation ', 'Elixinol ', 'NuLeaf Naturals, LLC ', 'Isodiol International, Inc. ', 'PharmaHemp ', 'The Cronos Group ', 'APHRIA, INC. ', 'AURORA CANNABIS ', 'MARICANN, INC. (WAYLAND GROUP CORPORATION) ', 'TILRAY ', 'GW PHARMACEUTICALS, PLC ', 'ABCANN MEDICINALS, INC. ', 'ORGANIGRAM HOLDING, INC. ', 'Hemptown USA ', 'Charlotte's Web Holdings ', 'CV Sciences ', 'Medterra CBD'

Growing Legalization of Cannabis

Sustainability and Organic Trends: Cannabidiol companies can focus on making their products 100% sustainable to ride the sustainability wave and boost sales. Market players can also focus on sourcing organic raw materials to make their cannabidiol products organic as the popularity of organic products rise around the world.

Growing awareness regarding the health benefits of cannabidiol and increasing legalization of cannabidiol are projected to help North America dominate the global market growth. Rising health consciousness, growing availability of cannabidiol products, and rising acceptance of the same are slated to bolster the sales of cannabidiol in the future. Canada and the United States will remain the most opportune markets for cannabidiol companies in this region. The presence of key cannabidiol providers will also aid the dominance of this region going forward.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Global Cannabidiol Market

Report ID: SQMIG35I2339

$5,300
BUY NOW GET FREE SAMPLE